Filter News
Area of Research
- (-) Isotopes (6)
- (-) Nuclear Science and Technology (14)
- Advanced Manufacturing (3)
- Biological Systems (1)
- Biology and Environment (38)
- Building Technologies (1)
- Clean Energy (40)
- Climate and Environmental Systems (1)
- Computational Biology (2)
- Computational Engineering (3)
- Computer Science (14)
- Fusion and Fission (9)
- Fusion Energy (8)
- Materials (38)
- Materials for Computing (10)
- Mathematics (1)
- National Security (28)
- Neutron Science (26)
- Nuclear Systems Modeling, Simulation and Validation (1)
- Quantum information Science (8)
- Supercomputing (123)
News Type
News Topics
- (-) Advanced Reactors (10)
- (-) Biomedical (7)
- (-) Computer Science (3)
- (-) Transformational Challenge Reactor (3)
- 3-D Printing/Advanced Manufacturing (4)
- Bioenergy (1)
- Climate Change (1)
- Coronavirus (1)
- Decarbonization (1)
- Energy Storage (1)
- Environment (1)
- Fusion (8)
- Irradiation (1)
- Isotopes (29)
- Materials (4)
- Materials Science (5)
- Molten Salt (4)
- National Security (1)
- Neutron Science (4)
- Nuclear Energy (36)
- Physics (2)
- Security (1)
- Space Exploration (9)
- Sustainable Energy (1)
Media Contacts
Raina Setzer knows the work she does matters. That’s because she’s already seen it from the other side. Setzer, a radiochemical processing technician in Oak Ridge National Laboratory’s Isotope Processing and Manufacturing Division, joined the lab in June 2023.
Researchers at ORNL explored radium’s chemistry to advance cancer treatments using ionizing radiation.
More than 50 current employees and recent retirees from ORNL received Department of Energy Secretary’s Honor Awards from Secretary Jennifer Granholm in January as part of project teams spanning the national laboratory system. The annual awards recognized 21 teams and three individuals for service and contributions to DOE’s mission and to the benefit of the nation.
As a medical isotope, thorium-228 has a lot of potential — and Oak Ridge National Laboratory produces a lot.
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.
When Sandra Davern looks to the future, she sees individualized isotopes sent into the body with a specific target: cancer cells.
A developing method to gauge the occurrence of a nuclear reactor anomaly has the potential to save millions of dollars.
It’s a new type of nuclear reactor core. And the materials that will make it up are novel — products of Oak Ridge National Laboratory’s advanced materials and manufacturing technologies.
As CASL ends and transitions to VERA Users Group, ORNL looks at the history of the program and its impact on the nuclear industry.
Oak Ridge National Laboratory researchers have discovered a better way to separate actinium-227, a rare isotope essential for an FDA-approved cancer treatment.